Sunday, April 30, 2017 6:25:17 AM
https://www.investing.com/analysis/biotech-stock-immunovaccine-at-all-time-high,-breaking-out-200186099
It was only 2 months ago when we wrote that biotech stock Immunovaccine had strong bullish momentum. That was the momentum we spotted quite some upside potential in that stock.
At the time of writing Immunovaccine Inc (TO:IMV) had a market cap of $104M. Meantime, it has reached $176M.
Immunovaccine has a candidate for one of the hard-to-treat forms of cancer (ovarian cancer). The company keeps on announcing encouraging test results, which feeds the assumption that is well on its way to have potentially a breakthrough treatment of ovarian cancer.
We wrote in February that stocks in momentum typically run out of steam after some weeks or even days. Immunovaccine went 20 percent higher after that call, retraced till $1.00, and rallied sharply higher to touch all-time highs at $1.50 per share today. That happened on very high volume which suggests a lot of buying interest as prices are skyrocketing. That is definitely a very solid sign of investment interest, one that should not be ignored.
InvestingHaven considers this setup to be a breakout: all-time highs on increasing volume, after 4 attempts, is very promising. This stock will probably trade at $2.00 in no time.
It still has ten-bagger potential.
Recent IMV News
- IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets • Business Wire • 09/01/2023 08:00:00 PM
- IMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process • Business Wire • 07/26/2023 11:05:00 AM
- IMV Receives NASDAQ Delisting Notice • Business Wire • 05/08/2023 08:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM